Literature DB >> 8436256

Nerve function and its determinants in patients with newly-diagnosed type 2 (non-insulin-dependent) diabetes mellitus and in control subjects--a 5-year follow-up.

J M Lehtinen1, L Niskanen, K Hyvönen, O Siitonen, M Uusitupa.   

Abstract

In order to assess the changes in nerve function 5 years after the diagnosis of diabetes mellitus and the determinants of progression of neuropathy, we studied 113 Type 2 (non-insulin-dependent) diabetic patients and 127 non-diabetic control subjects. Motor and sensory nerve conduction velocities were measured at the time of diagnosis of diabetes and 5 years later. At both examinations conduction velocities and response amplitudes were lower in diabetic patients than in control subjects. During the follow-up sural nerve conduction was impaired in both diabetic and control subjects, but, in general, changes in neurophysiological parameters were slight and inconsistent. In 12 diabetic patients nerve function deteriorated significantly during the follow-up. These patients had higher glycaemic indices at both examinations and lower baseline blood pressure levels as compared to the rest of the diabetic patients. No differences between these patient groups were found in other baseline risk factors (age, obesity, use of alcohol, smoking, serum insulin levels, albuminuria, lipids). In conclusion, Type 2 diabetic patients have disturbed nerve function at the time of diagnosis, but neurophysiological impairment during the next 5 years is on the average slight. Poor glycaemic control seems to be the most important risk factor in the deterioration of nerve function in these patients.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8436256     DOI: 10.1007/bf00399096

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  19 in total

1.  Neurologic complications of diabetes mellitus: transient ischemic attack, stroke, and peripheral neuropathy.

Authors:  P J Palumbo; L R Elveback; J P Whisnant
Journal:  Adv Neurol       Date:  1978

2.  Improvement in nerve conduction following treatment in newly diagnosed diabetics.

Authors:  J D Ward; C G Barnes; D J Fisher; J D Jessop; R W Baker
Journal:  Lancet       Date:  1971-02-27       Impact factor: 79.321

3.  Five-year follow-up study on plasma insulin levels in newly diagnosed NIDDM patients and nondiabetic subjects.

Authors:  L K Niskanen; M I Uusitupa; H Sarlund; O Siitonen; K Pyörälä
Journal:  Diabetes Care       Date:  1990-01       Impact factor: 19.112

4.  Worsening to diabetes in men with impaired glucose tolerance ("borderline diabetes").

Authors:  R J Jarrett; H Keen; J H Fuller; M McCartney
Journal:  Diabetologia       Date:  1979-01       Impact factor: 10.122

5.  Prevalence of neuropathy in newly diagnosed NIDDM and nondiabetic control subjects.

Authors:  J M Lehtinen; M Uusitupa; O Siitonen; K Pyörälä
Journal:  Diabetes       Date:  1989-10       Impact factor: 9.461

6.  Age-related changes in peripheral and central nerve conduction in man.

Authors:  L J Dorfman; T M Bosley
Journal:  Neurology       Date:  1979-01       Impact factor: 9.910

7.  Peripheral arterial disease and its relationship to cardiovascular risk factors and coronary heart disease in newly diagnosed non-insulin-dependent diabetics.

Authors:  O Siitonen; M Uusitupa; K Pyörälä; E Voutilainen; E Länsimies
Journal:  Acta Med Scand       Date:  1986

8.  Prevalence of diabetic complications in relation to risk factors.

Authors:  M W Knuiman; T A Welborn; V J McCann; K G Stanton; I J Constable
Journal:  Diabetes       Date:  1986-12       Impact factor: 9.461

9.  Glycemic control and nerve conduction abnormalities in non-insulin-dependent diabetic subjects.

Authors:  R J Graf; J B Halter; M A Pfeifer; E Halar; F Brozovich; D Porte
Journal:  Ann Intern Med       Date:  1981-03       Impact factor: 25.391

10.  Effect of alcohol intake on symptomatic peripheral neuropathy in diabetic men.

Authors:  D K McCulloch; I W Campbell; R J Prescott; B F Clarke
Journal:  Diabetes Care       Date:  1980 Mar-Apr       Impact factor: 19.112

View more
  10 in total

1.  Reliability of quantitative sudomotor axon reflex testing and quantitative sensory testing in neuropathy of impaired glucose regulation.

Authors:  Amanda Peltier; A Gordon Smith; James W Russell; Kiran Sheikh; Billie Bixby; James Howard; Jonathan Goldstein; Yanna Song; Lily Wang; Eva L Feldman; J Robinson Singleton
Journal:  Muscle Nerve       Date:  2009-04       Impact factor: 3.217

2.  Treatment of diabetic sensory polyneuropathy.

Authors:  Lindsay Zilliox; James W Russell
Journal:  Curr Treat Options Neurol       Date:  2011-04       Impact factor: 3.598

Review 3.  Insulin sensitivity and complications in type 1 diabetes: New insights.

Authors:  Petter Bjornstad; Janet K Snell-Bergeon; Kristen J Nadeau; David M Maahs
Journal:  World J Diabetes       Date:  2015-02-15

Review 4.  The Effect of Cigarette Smoking on Diabetic Peripheral Neuropathy: A Systematic Review and Meta-Analysis.

Authors:  Carole Clair; Marya J Cohen; Florian Eichler; Kevin J Selby; Nancy A Rigotti
Journal:  J Gen Intern Med       Date:  2015-05-07       Impact factor: 5.128

Review 5.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

6.  Standing balance and trunk position sense in impaired glucose tolerance (IGT)-related peripheral neuropathy.

Authors:  Allon Goldberg; James William Russell; Neil Burton Alexander
Journal:  J Neurol Sci       Date:  2008-04-25       Impact factor: 3.181

7.  The realistic yield of lower leg SNAP amplitudes and SRAR in the routine evaluation of chronic axonal polyneuropathies.

Authors:  A F J E Vrancken; N C Notermans; J H J Wokke; H Franssen
Journal:  J Neurol       Date:  2008-08-24       Impact factor: 4.849

8.  Update on the management of diabetic polyneuropathies.

Authors:  Jayadave Shakher; Martin J Stevens
Journal:  Diabetes Metab Syndr Obes       Date:  2011-07-21       Impact factor: 3.168

9.  Quantitative assessment of early biomechanical modifications in diabetic foot patients: the role of foot kinematics and step width.

Authors:  Giuseppe Lamola; Martina Venturi; Dario Martelli; Elisabetta Iacopi; Chiara Fanciullacci; Alberto Coppelli; Bruno Rossi; Alberto Piaggesi; Carmelo Chisari
Journal:  J Neuroeng Rehabil       Date:  2015-11-09       Impact factor: 4.262

10.  Using Skin Bioengineering to Highlight How Weight and Diabetes Mellitus Modify the Skin in the Lower Limbs of Super-Obese Patients.

Authors:  Elisabetta Iacopi; Nicola Riitano; Valentina Dini; Rossana Berta; Letizia Pieruzzi; Agata Janowska; Marco Anselmino; Alberto Piaggesi; Marco Romanelli
Journal:  Diabetes Metab Syndr Obes       Date:  2020-03-16       Impact factor: 3.168

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.